TCF12 and neoplasm: Knockdown of TCF12 significantly impaired the growth of YUMM1.7 tumors, as evidenced by slower tumor growth kinetics (Figure 2e) and smaller tumor size at the endpoint (Figure 2f,g), in line with a lower proliferation index by Ki67 IHC (Figure 2h,i).